JPRN-UMIN000048941
Not yet recruiting
未知
Clinical study on long-term follow-up of patients treated with PDT - Clinical study on long-term follow-up of patients treated with PDT
agasaki-university hospital0 sites40 target enrollmentSeptember 15, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- agasaki-university hospital
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Cases undergoing PDT treatment for recurrent cases after surgical treatment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
ong-term clinical follow-up study of patients and families with choroideremia for future clinical trialsCHMChoroideremiatapetochoroideal dystrophy (TCD)1001592010010463NL-OMON38958Academisch Medisch Centrum50
Active, not recruiting
Phase 1
A long-term follow-up study for patients treated with Galapagos CAR T cell therapiesRelapsed/refractory B-Cell non-Hodgkin lymphoma, Relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Relapsed/refractory multiple myelomaMedDRA version: 21.0Level: LLTClassification code: 10051812Term: Small cell lymphocytic lymphoma Class: 10029104MedDRA version: 20.0Level: HLGTClassification code: 10025320Term: Lymphomas non-Hodgkin's B-cell Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2023-510173-34-00Galapagos300
Recruiting
Not Applicable
A study to evaluate clinical factors responsible for functional and cognitive outcome after stroke in ischemic stroke patients.CTRI/2020/01/022783Kasturba Medical College Manipal
Recruiting
Not Applicable
Role of steroids in IgA nephropathy and correlation with Oxford MEST ClassificatioHealth Condition 1: N08- Glomerular disorders in diseases classified elsewhereHealth Condition 2: null- Primary Immunoglobulin A NephropathyCTRI/2017/02/007768Department of NephrologyIPGMER Kolkata30
Completed
Phase 4
To evaluate safety and performance of the BioMimeâ?¢- Sirolimus Eluting Coronary Stent System in the treatment of patients during a pre-defined period.Health Condition 1: I259- Chronic ischemic heart disease, unspecifiedCTRI/2017/10/009968Meril Life Sciences Pvt Ltd1,161